4
Changes in Ownership
Coherus Oncology, Inc. Filed Acc 0000899243-19-017621
Chief Financial Officer sold 6,826 shares at an average $19.85 ($135,514)
- Chief Financial Officer acquired 3,159 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Viret Jean-Frederic · Chief Financial Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-06-18 | Sale : show line 1 in the form | −3,000 | $19.31 | $57,926 | 12,180 | D |
| 2019-06-19 | Sale : show line 2 in the form | −667 | $20.00 | $13,340 | 11,513 | D |
| 2019-06-19 | Exercise or conversion : show line 3 in the form | +3,159 | $10.05 | $31,748 | 14,672 | D |
| 2019-06-19 | Sale : show line 4 in the form | −3,059 | $20.32 | $62,166 | 11,613 | D |
| 2019-06-19 | Sale : show line 5 in the form | −100 | $20.81 | $2,081 | 11,513 | D |
| Open-market sales · 6,826 sh · avg $19.85 · $135,514 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-06-19 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −3,159 | 126,841 | D |
Loading xslF345X03/doc4.xml…